3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Head & Neck
1
Gynecologic
1
Conditions
Multiple Myeloma
7
Pain, Postoperative
5
Pain
4
Parkinson Disease 4, Autosomal Dominant Lewy Body
3
Burkitt Lymphoma
3
Prostatic Neoplasms
2
Precursor Cell Lymphoblastic Leukemia-Lymphoma
2
Neoplasms
2
Neoplasm Metastasis
2
Lymphoma, Non-Hodgkin
2
Lymphoma
2
Lung Neoplasms
2
Leukemia, Hairy Cell
2
Hodgkin Disease
2
Carcinoma, Non-Small-Cell Lung
2
Carcinoma in Situ
2
Breast Neoplasms
2
Agnosia
2
Vulvar Neoplasms
1
Vulvar Diseases
1
Uterine Cervical Neoplasms
1
Uterine Cervical Dysplasia
1
Urinary Bladder Neoplasms
1
Triple Negative Breast Neoplasms
1
Squamous Cell Carcinoma of Head and Neck
1
Skin Neoplasms
1
Sarcoma, Alveolar Soft Part
1
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
1
Papillomavirus Infections
1
Ovarian Neoplasms
1
Interventions
pembrolizumab
34
Cisplatin
29
Paclitaxel
15
Brachytherapy
15
Radiotherapy
14
Carboplatin
14
Bevacizumab
14
Blood Specimen Collection
13
Specimen Handling
12
Magnetic Resonance Spectroscopy
11
Colposcopy
11
Nivolumab
10
Drug Therapy
10
atezolizumab
8
Human Papillomavirus DNA Tests
8
Gemcitabine
8
lenvatinib
7
Radiation
6
Platinum
6
Biopsy
6
toripalimab
5
cemiplimab
5
Surveys and Questionnaires
5
Standard of Care
5
Radiotherapy, Intensity-Modulated
5
Practice Guidelines as Topic
5
Patient Navigation
5
Fulvestrant
5
Fluorodeoxyglucose F18
5
zimberelimab
4
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Uterine Cervical Neoplasms
×
Acetaminophen
×
1 year
×
Clear all
NCT02439034
2026-03-16
KETOCOL
Centre Oscar Lambret
Phase 2
Completed
68 enrolled